Stefan Fröhling
Runs the NCT/DKTK MASTER programme that sequences whole genomes of rare and young-adult cancers to guide therapy.
Stefan Fröhling leads the MASTER precision oncology programme and the NCT Heidelberg, with a focus on sarcomas and rare cancers and on turning genomic findings into molecularly guided treatment.
| Title | Journal | Year |
|---|---|---|
| Comprehensive genomic and transcriptomic analysis for guiding therapeutic decisions in patients with rare cancers (MASTER) | Cancer Discovery | 2021 |
Pages like this
not linked directly; found by shared links- PersonAndreas von Deimling
Shares Heidelberg University Hospital / NCT / DKFZ, German Cancer Research Center (DKFZ).
- PersonStefan Pfister
Shares Heidelberg University Hospital / NCT / DKFZ, German Cancer Research Center (DKFZ).
- PersonShunji Takahashi
Shares Comprehensive genomic profiling, Sarcomas (soft tissue, bone, GIST).
- CompanyValius Sciences
Shares Whole-exome & whole-genome sequencing, Comprehensive genomic profiling.
- CompanyCaris Life Sciences
Shares Whole-exome & whole-genome sequencing, Comprehensive genomic profiling.
- InstitutionGarvan Institute of Medical Research / Kinghorn Cancer Centre
Shares Whole-exome & whole-genome sequencing, Comprehensive genomic profiling, Sarcomas (soft tissue, bone, GIST).
- IdeaA standard evolvability score for every tumour
Shares Whole-exome & whole-genome sequencing, Comprehensive genomic profiling.
- InstitutionOntario Institute for Cancer Research
Shares Whole-exome & whole-genome sequencing, Comprehensive genomic profiling.